AU2013201110A1 - Endoluminal prosthetic conduit systems and method of coupling - Google Patents

Endoluminal prosthetic conduit systems and method of coupling Download PDF

Info

Publication number
AU2013201110A1
AU2013201110A1 AU2013201110A AU2013201110A AU2013201110A1 AU 2013201110 A1 AU2013201110 A1 AU 2013201110A1 AU 2013201110 A AU2013201110 A AU 2013201110A AU 2013201110 A AU2013201110 A AU 2013201110A AU 2013201110 A1 AU2013201110 A1 AU 2013201110A1
Authority
AU
Australia
Prior art keywords
conduit
open end
main
prosthetic
main conduit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013201110A
Other versions
AU2013201110B2 (en
Inventor
Rochelle M. Hamer
Stanislaw L. Zukowski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WL Gore and Associates Inc
Original Assignee
Gore Enterprise Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008284355A external-priority patent/AU2008284355B2/en
Application filed by Gore Enterprise Holdings Inc filed Critical Gore Enterprise Holdings Inc
Priority to AU2013201110A priority Critical patent/AU2013201110B2/en
Publication of AU2013201110A1 publication Critical patent/AU2013201110A1/en
Application granted granted Critical
Publication of AU2013201110B2 publication Critical patent/AU2013201110B2/en
Assigned to W. L. GORE & ASSOCIATES, INC. reassignment W. L. GORE & ASSOCIATES, INC. Request for Assignment Assignors: GORE ENTERPRISE HOLDINGS, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Prostheses (AREA)

Abstract

Abstract A modular prosthetic conduit system such as a stent or stent graft system tailored for the repair of aneurysms or other compromised vessel walls. A 5 prosthetic conduit system as described includes: an expandable main conduit having a first open end, a second open end, a main conduit wall extending therebetween, at least one opening through the main conduit wall, and an internal channel having an inner surface, an outer surface, a first open end located within the main conduit, and a second open end at the opening in the 10 main conduit wall; an expandable secondary conduit extending through the internal channel and outwardly through the opening in the main conduit wall, the secondary conduit having a longitudinal axis extending between a first open end and a second open end of the secondary conduit, the secondary conduit having a secondary conduit wall extending between the first open end and the is second open end of the secondary conduit, and an attachment portion extending outwardly from the main conduit wall at an angle of less than 90 degrees relative to the secondary conduit axis when in a deployed state and engaging a portion of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit. 4111574_1 (GHMatters) P83106.AU.1 26/02/13

Description

- 1 TITLE PROSTHETIC CONDUITS AND PROSTHETIC CONDUIT SYSTEMS 5 The present application claims divisional status from Australian standard patent/application No. 2008284355. FIELD OF THE INVENTION 10 The present invention relates to endoluminal prosthetic conduit systems and in particular to methods and components for joining together endoluminal prosthetic conduit components. 15 BACKGROUND OF THE INVENTION Stents or stent grafts are forms of transluminal prosthetic components which are used to maintain, open or dilate stenotic lesions in body lumens or to cover and repair an aneurysm. It is often the case that an aneurysm occurs at a 20 branch or bifurcation in a vessel. To repair such an aneurysm using modular components, one current technique is to initially deploy across the aneurysm a main body stent or stent graft having a side wall opening. The side wall opening is aligned with the side branch ostium. A second stent or stent graft is then deployed through the main body stent side wall opening and into the side 25 branch vessel. This modular repair approach requires the modular components to be effectively sealed at their connection points to prevent blood leakage into the aneurysm. In addition the modular components must be locked or joined together to prevent subsequent relative displacement of the modular components. Similar requirements apply to those procedures that use multiple 30 stent grafts that are coupled together to increase the effective length of the repair device. SUMMARY OF THE INVENTION 35 The present invention provides modular prosthetic conduit systems such as stent or stent graft systems. The modular prosthetic conduit systems may be tailored for the repair of aneurysms or for the repair of compromised vessel 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 2 walls. The systems incorporate various embodiments for the secure interlocking of the multiple modular components used in a vessel repair procedure. An aspect of the invention includes a prosthetic conduit system comprising: 5 an expandable main conduit having a first open end, a second open end, a main conduit wall extending therebetween, at least one opening through the main conduit wall, and an internal channel having an inner surface, an outer surface, a first open end located within the main conduit, and a second open end at the opening in the main conduit wall; 10 an expandable secondary conduit extending through the internal channel and outwardly through the opening in the main conduit wall, the secondary conduit having a longitudinal axis extending between a first open end and a second open end of the secondary conduit, the secondary conduit having a secondary conduit wall extending between the first open end and the second is open end of the secondary conduit, and an attachment portion extending outwardly from the main conduit wall at an angle of less than 90 degrees relative to the secondary conduit axis when in a deployed state and engaging a portion of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit, 20 wherein the inner surface of the internal channel comprises at least one protuberance extending generally radially inwardly therefrom, wherein the attachment portion engages the protuberance on the inner surface of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit at least in a direction of blood flow 25 therethrough. Also described herein is a prosthetic conduit system comprising: an expandable main conduit having a first open end, a second open end, a main conduit wall extending therebetween, an outer conduit surface, and an inner conduit surface having at least one protuberance thereon; an expandable 30 secondary conduit having a first open end, a second open end, a secondary conduit wall extending therebetween, and attachment portion extending at an angle of less than 90 degrees from the secondary conduit wall when in a 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 3 deployed state; and wherein at least a portion of the secondary conduit is sized to fit inside the main conduit. A further aspect of the invention includes a prosthetic conduit comprising: 5 an expandable main conduit having a first open end, a second open end, a main conduit wall extending therebetween, at least one opening through the main conduit wall, and an internal channel having an inner surface, an outer surface, a first open end located within the main conduit, and a second open end at the opening in the main conduit wall; 10 an expandable secondary conduit extending through the internal channel and outwardly through the opening in the main conduit wall, the secondary conduit having a longitudinal axis extending between a first open end and a second open end of the secondary conduit, the secondary conduit having a secondary conduit wall extending between the first open end and the second is open end of the secondary conduit, and an attachment portion extending outwardly from the main conduit wall at an angle of less than 90 degrees relative to the secondary conduit axis when in a deployed state and engaging a portion of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit, 20 wherein the attachment portion latchingly engages the first open end of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit at least in a direction of blood flow therethrough. Also described herein is a prosthetic conduit system comprising: an expandable main conduit having a first open end, a second open end, a main 25 conduit wall extending therebetween, at least one opening through the main conduit wall, and an internal channel having an inner surface, an outer surface, a first open end located within the main conduit and a second open end at the opening in the main conduit wall; an expandable secondary conduit having a first open end, a second open end, a secondary conduit wall extending 30 therebetween, and attachment portion extending at an angle of less than 90 degrees from the secondary conduit wall when in a deployed state; and wherein 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 4 at least a portion of the secondary conduit is sized to fit inside the internal channel and through the opening in the main conduit wall. BRIEF DESCRIPTION OF THE DRAWINGS 5 Figure 1 is a side view of a main conduit with an interconnected secondary conduit as implanted across an aortic aneurysm. Figure 2 is a perspective view of a main conduit having an internal protuberance. io Figure 3 is a cross-sectional view of a main conduit having an internal protuberance. Figure 4 is a perspective view of a main conduit joined to a secondary conduit. Figures 5A and 5B are perspective and side views of a secondary is conduit having an attachment portion. Shown is a defined angle between an attachment portion and a secondary conduit longitudinal axis or secondary conduit wall. Figure 6 is a cross-sectional view of a main conduit having an internal protuberance that is discontinuous or segmented. 20 Figure 7 is a cross-sectional view of a main conduit having an internal protuberance that incorporates stiffening support structures. Figure 8 is a cross-sectional view of a main conduit having an internal stent or support structure with barbs or hooks configured to engage a secondary conduit. 25 Figures 9A and 9B are cross-sectional views of a main conduit having internal barbs or internal hooks configured to engage a secondary conduit. Figures 1 0A and 1OB are perspective views of a secondary conduit having external barbs or external hooks configured to engage a main conduit. Figure 11 is a perspective view of a secondary conduit having an 30 external cuff that is configured to engage and lock onto an open end of a support channel. Figure 12 is a cross-sectional view of a main conduit having two opposed cuffs. Figure 13 is a side view of a secondary conduit having two opposed 35 cuffs. 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 5 Figure 14 is a perspective view of a main conduit and an interconnected secondary conduit. Figures 15 A and 15B are side views of main conduits according to certain aspects of the invention. 5 Figures 16 A and 16B are side views of main conduits and secondary conduits according to certain aspects of the invention. DETAILED DESCRIPTION OF THE INVENTION io A better understanding of the invention will be had with reference to the several figures. Shown in Figure 1 is a main conduit 20 having a first open end 22 and a second open end 24. A secondary conduit 26 is shown inserted into the second open end 24 of the main conduit 20. The secondary conduit 26 is is shown as a bifurcated endoluminal device bridging an aortic aneurysm 28. The main conduit 20 and the secondary conduit 26 are expanded and share an engagement portion or engagement length 30. In an aspect of the invention the main conduit 20 and the secondary conduit 26 can be self-expanding or balloon expandable. 20 A main conduit can have various configurations including stent grafts with or without side-branches or side-branch openings. Stent grafts can be fabricated, for example, according to the methods and materials as generally disclosed in US Patent Nos. 6,042,605; 6,361,637; and 6,520,986 all to Martin et al. Details relating to the fabrication and materials used for a main conduit 25 with an internal side branch support tube or channel can be found in, for example, US Patent No. 6,645,242 to Quinn. The main conduit comprises at least one protuberance on the inner surface of the main conduit. Protuberances according to an aspect of the invention can be in many forms. For example, shown in Figure 2 is a 30 perspective view of a main conduit 20 having a first open end 22 and a second open end 24. Internal to the main conduit is protuberance in the form of cuff 32 on the inner surface of the main conduit. Figure 3 is a cross-sectional view of a main conduit 20 as viewed along the cross-sectional plane 3 of Figure 2. Shown is a section of a main conduit 35 20, first and second open ends 22, 24 and protuberance 32. The protuberance 32 is in the form of a cuff 34 that is configured to engage an attachment portion of a secondary conduit. A protuberance or cuff can have various configurations 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 6 and can be fabricated, for example, from tubes, sheets or films formed into tubular shapes, woven or knitted fibers or ribbons or combinations thereof. Protuberance or cuff materials can include conventional medical grade materials such as nylon, polyester, polyethylene, polypropylene, 5 polytetrafluoroethylene, polyvinylchloride, polyurethane and elastomeric organosilicon polymers. A protuberance or cuff can be joined to a graft or stent wall by sutures, medical grade adhesives or thermoplastics or can be integral to the graft or stent wall. Shown in Figure 4 is a main conduit 20 having a first open end 22 and a 10 second open end 24 and a wall 25 extending between the two open ends. The wall defines an outer conduit surface 21 and an inner conduit surface 23. A secondary conduit 26 is shown inserted into the second open end 24 of the main conduit 20. The secondary conduit 26 has a first open end 27 a second open end 29 and a wall 31 extending between the two open ends. The is secondary conduit 26 has an attachment portion 36 shown in a deployed state as flared apices of a stent support structure. The attachment portion 36 is shown engaged into the protuberance 32 of main conduit 20. The flared apices of the stent support are therefore engaged and interlocked into the cuff 34, preventing or inhibiting the secondary conduit 26 from dislodging toward the 20 direction indicated by arrow 38. An improved sealing surface between the secondary and the main conduits may also be provided by the protuberance 32. Forces exerted by the flow of blood may encourage or drive the flared apices of the stent support into contact with or full engagement with the cuff 34. Shown in Figure 5A is a secondary conduit 26 having open ends 27 and 25 29, a wall 31 extending from open end 27 to open end 29, a longitudinal axis 40 and attachment portion 36 shown in an unconstrained or deployed state as flared-out apices of a support stent. The inner surface 42 of the attachment portion 36 defines axis 44. An angle 46 is shown between the secondary conduit longitudinal axis 40 (and the wall 31) and the attachment portion axis 30 44. Shown is an angle of about 45. Angle 46 can be any angle less than about 90. For example angle 46 can be just less than 90', about 80, about 70, about 60, about 45, about 30, about 20'or less. Similar to Figure 5A, shown in Figure 5B is a secondary conduit 26 having open ends 27 and 29, a wall 31 extending from open end 27 to open 35 end 29, a longitudinal axis 40 and an attachment portion 36 shown in a deployed state as flared-out apices of a support stent. The inner surface 42 of the attachment portion 36 defines axis 44. An angle 46' is shown between the 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 7 secondary conduit wall 31 and the attachment portion axis 44. Shown is an angle of about 45. Various alternate configurations of attachment portions and/or protuberances are possible. For example the protuberance 32 can be 5 discontinuous, forming discrete protuberance segments along the inner wall of a main conduit. A main conduit can have two, three, four or five or more discrete protuberance segments, spaced along the inner wall. Shown in Figure 7 is a cross-sectional view of a main conduit 20 as viewed along the cross sectional plane 3 as defined in Figure 2. Shown is a section of a main conduit 10 20, first and second open ends 22, 24 and discontinuous protuberances 34. The protuberances 34 form a series of cuffs that are configured to engage attachment portions of a secondary conduit, such as depicted in Figure 4. To assist in the engagement of an attachment portion, a protuberance can incorporate semi-rigid or densified segments along its length. Such semi is rigid sections along a protuberance may prevent or inhibit the protuberance from collapsing. Shown in Figure 8 is a cross-sectional view of a main conduit 20 as viewed along the cross-sectional plane 3 as defined in Figure 2. Shown is a section of a main conduit 20, first and second open ends 22, 24 and a protuberance, shown as cuff 34. Densified or semi-rigid sections 62 are 20 incorporated into the protuberance to add rigidity to cuff 34 and thus inhibiting or even preventing the cuff from collapsing. Semi-rigid sections 62 can be incorporated into segmented or discontinuous protuberances as previously described in Figure 7. Semi-rigid or densified segments may be formed from conventional 25 medical grade materials such as nylon, polyacrylamide, polycarbonate, polyethylene, polyformaldehyde, polymethylmethacrylate, polypropylene, polytetrafluoroethylene, polytrifluorochlorethylene, polyvinylchloride, polyurethane, elastomeric organosilicon polymers; metals such as stainless steels, cobalt-chromium alloys and nitinol and biologically derived materials 30 such as pericardium and collagen. Semi-rigid or densified segments can also comprise bioresorbable materials such as poly(amino acids), poly(anhydrides), poly(caprolactones), poly(lactic/glycolic acid) polymers, poly(hydroxybutyrates) and poly(orthoesters). The at least one protuberance of the main conduit may comprise an 35 internal stent or support structure that incorporates barbs, hooks or other suitable configurations to engage and/or lock with a secondary conduit. Shown in Figure 9 is a cross-sectional view of a main conduit 20 as viewed along the 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 8 cross-sectional plane 3 of Figure 2. Shown is a section of a main conduit 20, first and second open ends 22, 24 and an internal stent or support structure 64. Protruding out of the stent or support structure 64 are a series of barbs or hooks 66. The barbs or hooks are oriented inwards toward the center of the 5 main conduit and are configured to engage and/or lock onto a wall or attachment portion of a secondary conduit. A main conduit may have a series of internal, barbs or hooks that are integral to the main conduit wall or integral to a main conduit support stent. For example if the main conduit has a stent support structure, portions of the stent 10 can be formed into hooks or barbs that are configured to engage and lock a secondary conduit. Shown in Figure 1 0A is a cross-sectional view of a main conduit 20 as viewed along the cross-sectional plane 3 of Figure 2. Shown is a section of a main conduit 20, first and second open ends 22, 24 and a series of internal barbs 68. Similarly shown in Figure 10B are a series of internal hooks is 70. The barbs or hooks are oriented inwards toward the center of the main conduit and are configured to engage and/or lock onto an external wall of a secondary conduit. Barbs or hooks may be formed from conventional medical grade materials such as those listed above. Secondary conduits can also incorporate various forms of attachment 20 portions to engage and/or lock onto main conduits. For example shown in Figure 1 1A is a perspective view of a secondary conduit 26 having first and second open ends 27, 29 and a wall 31. Protruding outwardly away from the secondary conduit wall 31 are a series of external barbs 72. Similarly, shown in Figure 11 B are a series of external hooks 74. The barbs or hooks are oriented 25 outwardly away from the center of the secondary conduit and are configured to engage and lock onto an internal wall and/or protuberance of a main conduit. A secondary conduit may also incorporate an external cuff that is configured to engage a main body protuberance or an open end of an internal channel. For example shown in Figure 12 is a perspective view of a secondary 30 conduit 26 having first and second open ends 27, 29 and a wall 31. Formed about the first open end 27 is an external cuff 76 configured to engage an internal protuberance or a first open end of an internal channel of a main conduit. The external cuff may incorporate semi-rigid sections as shown in Figure 7 to add rigidity to the cuff. 35 A main conduit may have opposed anchoring cuffs that prevent a secondary conduit from being displaced in two directions. Shown in Figure 13 is a cross-sectional view of a main conduit 20 having two opposed engagement 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 9 cuffs 78. The cuffs 78 are configured in a linear state as shown in Figure 2 and Figure 3 . The cuffs 78 are configured to engage attachment portions 36 of a secondary conduit 26. The engagement of the attachment portions 36 to the cuffs 78 inhibit or prevent dislodgement of the secondary conduit in the two 5 directions shown by arrows 38 and 80. Secondary conduits can also incorporate attachment portions in the form of bi-directional cuffs that inhibit or prevent dislodgement in two directions. Shown in Figure 14, is a secondary conduit 26 having bi-directional cuffs 82. The bi-directional cuffs 82 are configured to engage opposed main conduit cuffs 10 as shown in Figure 13. In some surgical procedures it is desirable to have a side-branched endovascular device, particularly for the repair of a vessel that is in close proximity to branched vasculature. Figure 14 is a perspective view of an alternate main conduit 50 having a is first open end 22 and a second open end 24. Within the main conduit 50 is an internal channel 54 having a first open end 56 and a second open end 58 that is aligned to an opening 60 in the main conduit wall 25. Such a main conduit can be fabricated according to the teaching in U.S. Patent No. 6,645,242 to Quinn. A secondary conduit 26 having a first open end 27, a second open end 29, a 20 wall 31, and an attachment portion 36 in a deployed state is shown inserted into the internal channel 54. The secondary conduit 26 is shown exiting out through the second open end 58 of the internal channel 54 and through the opening 60 in the main conduit wall. The attachment portion 36 is configured to engage and/or interlock onto the first open end 56 of the internal channel. This 25 interlocking may prevent the dislodgement of the secondary conduit 26 along the direction depicted by arrow 38. Forces exerted by the flow of blood may encourage or drive the attachment portion 36 into full contact with the first open end 56 of the internal channel 54. Stents can have various configurations as known in the art and can be 30 fabricated, for example, from cut tubes, wound wires (or ribbons) or flat patterned sheets rolled into a tubular form. Stents can be formed from metallic, polymeric or natural materials and can comprise conventional medical grade materials such as nylon, polyacrylamide, polycarbonate, polyethylene, polyformaldehyde, polymethylmethacrylate, polypropylene, 35 polytetrafluoroethylene, polytrifluorochlorethylene, polyvinylchloride, polyurethane, elastomeric organosilicon polymers; metals such as stainless steels, cobalt-chromium alloys and nitinol and biologically derived materials 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 10 such as bovine arteries/veins, pericardium and collagen. Stents can also comprise bioresorbable materials such as poly(amino acids), poly(anhydrides), poly(caprolactones), poly(lactic/glycolic acid) polymers, poly(hydroxybutyrates) and poly(orthoesters). 5 Grafts can have various configurations as known in the art and can be fabricated, for example, from tubes, sheets or films formed into tubular shapes, woven or knitted fibers or ribbons or combinations thereof. Graft materials can include conventional medical grade materials such as nylon, polyester, polyethylene, polypropylene, polytetrafluoroethylene (including expanded io polytetrafluoroethylene ("ePTFE")), polyvinylchloride, polyurethane and elastomeric organosilicon polymers. Stents can be used alone or in combination with graft materials. Stents can be configured on the external or internal surface of a graft or may be incorporated into the internal wall structure of a graft. Moreover, main and is secondary conduits can incorporate various stent or support structures. For example as shown in Figure 15A, a main conduit 20 may comprise separate stent segments 90A and 92A, positioned at or near the first and second open ends 22 and 24 of the main conduit 20. Similarly the stent segments 90A and 92A can comprise a single stent 94A extending from the first open end 22 to the 20 second open end 24 of the main conduit 20 as shown in Figure 15B. Shown in Figures 16A and 16B are secondary conduits 26 tailored to be inserted into main conduits 22 along direction arrows 96. As shown in Figure 16A, a secondary conduit 26 can incorporate stents 90B and 92B at or near the first and second open ends 27 and 29 of the secondary conduit 26. Similarly the 25 stent segments 90B and 92B can comprise a single stent 94B extending from the first open end 27 to the second open end 29 of the secondary conduit 26. Expandable conduits according to the invention can be delivered in a constrained state endoluminally by various catheter based procedures known in the art. For example self-expanding endoluminal devices can be loaded onto 30 the distal end of a catheter, compressed and maintained in a constrained state by an external sheath. The sheath can be folded to form a tube positioned external to the compressed device. The sheath edges can be sewn together with a deployment cord that forms a "chain stitch". Once the constrained device is positioned at a target site within a vessel the device can be deployed. In the 35 deployed state, the device may still be constrained by the vasculature or by another device. For example a device may assume a diameter of 20mm when fully un-constrained. This same device may be deployed into a vessel (or other 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 11 device) having a lumen diameter of 15mm and would therefore be "constrained" in the deployed state. An "un-constrained state" can therefore be defined as the state assumed by the device when there are no external forces inhibiting the full expansion of the device. A "constrained state" can therefore be defined as the 5 state assumed by the device in the presence of external forces that inhibit the full expansion of the device. The deployed state can be defined as the state assumed by the device when expanded into a vessel or other device. To release and deploy the constrained device, one end of the deployment cord can be pulled to disrupt the chain stitch, allowing the sheath 10 edges to separate and release the constrained device. Constraining sheaths and deployment cord stitching can be configured to release a self-expanding device in several ways. For example a constraining sheath may release a device starting from the proximal device end, terminating at the distal device end. In other configurations the device may be released starting from the distal is end. Self expanding devices may also be released from the device center as the sheath disrupts towards the distal and proximal device ends. Details relating to constraining sheath materials, sheath methods of manufacture and main body compression techniques can be found in US Patent No. 6,352,561 to Leopold et al., and US Patent No. 6,551,350 Thornton et al. 20 In the deployment of a secondary conduit for example, the secondary conduit can be released from a constraining sheath starting at the proximal (or hub) end of the constrained conduit. In typical procedures, the attachment portion of the secondary conduit is located about the proximal end of the conduit and in an aspect of the invention this proximal end is the first end 25 released from a constraining sheath, thus also deploying the attachment portion. While particular embodiments of the present invention have been illustrated and described above, the present invention should not be limited to such particular illustrations and descriptions. It should be apparent that 30 changes and modifications may be incorporated and embodied as part of the present invention within the scope of the following claims. In the claims which follow and in the preceding description of the invention, except where the context requires otherwise due to express language or necessary implication, the word "comprise" or variations such as 35 "comprises" or "comprising" is used in an inclusive sense, i.e. to specify the presence of the stated features but not to preclude the presence or addition of further features in various embodiments of the invention. 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 12 It is to be understood that, if any prior art publication is referred to herein, such reference does not constitute an admission that the publication forms a part of the common general knowledge in the art, in Australia or any other country. 5 4111574_1 (GHMatters) P83106.AU.1 26/02/13

Claims (19)

1. Prosthetic conduit system comprising: 5 an expandable main conduit having a first open end, a second open end, a main conduit wall extending therebetween, at least one opening through the main conduit wall, and an internal channel having an inner surface, an outer surface, a first open end located within the main conduit, and a second open end at the opening in the main conduit wall; 10 an expandable secondary conduit extending through the internal channel and outwardly through the opening in the main conduit wall, the secondary conduit having a longitudinal axis extending between a first open end and a second open end of the secondary conduit, the secondary conduit having a secondary conduit wall extending between the first open end and the second is open end of the secondary conduit, and an attachment portion extending outwardly from the main conduit wall at an angle of less than 90 degrees relative to the secondary conduit axis when in a deployed state and engaging a portion of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit, 20 wherein the inner surface of the internal channel comprises at least one protuberance extending generally radially inwardly therefrom, wherein the attachment portion engages the protuberance on the inner surface of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit at least in a direction of blood flow 25 therethrough.
2. The prosthetic conduit system of claim 1, wherein the at least one protuberance extends at an angle of less than 90 degrees relative to a longitudinal axis of the internal channel. 30
3. A prosthetic conduit comprising: an expandable main conduit having a first open end, a second open end, a main conduit wall extending therebetween, at least one opening through the 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 14 main conduit wall, and an internal channel having an inner surface, an outer surface, a first open end located within the main conduit, and a second open end at the opening in the main conduit wall; an expandable secondary conduit extending through the internal channel 5 and outwardly through the opening in the main conduit wall, the secondary conduit having a longitudinal axis extending between a first open end and a second open end of the secondary conduit, the secondary conduit having a secondary conduit wall extending between the first open end and the second open end of the secondary conduit, and an attachment portion extending 10 outwardly from the main conduit wall at an angle of less than 90 degrees relative to the secondary conduit axis when in a deployed state and engaging a portion of the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit, wherein the attachment portion latchingly engages the first open end of is the internal channel to constrain axial displacement of the secondary conduit relative to the main conduit at least in a direction of blood flow therethrough.
4. The prosthetic conduit system of claim 1, wherein the expandable main conduit is balloon expandable. 20
5. The prosthetic conduit system of claim 1, wherein the expandable main conduit is self-expanding.
6. The prosthetic conduit system of claim 1, wherein the at least one 25 protuberance is selected from the group consisting of barbs, cuffs, hooks, flanges, stent apices and rings.
7. The prosthetic conduit system of claim 1, wherein the main conduit comprises a graft material. 30
8. The prosthetic conduit system of claim 1, wherein the secondary conduit comprises a graft material.
9. The prosthetic conduit system of claim 7, wherein the graft material 35 comprises ePTFE. 4111574_1 (GHMatters) P83106.AU.1 26/02/13 - 15
10. The prosthetic conduit system of claim 8, wherein in the graft material comprises ePTFE. 5
11. The prosthetic conduit system of claim 1, wherein the expandable main conduit comprises a first stent segment at the first open end and a second stent segment at the second open end.
12. The prosthetic conduit system of claim 11, wherein the first stent segment 10 and the second stent segment comprise a single stent extending from the first open end to the second open end.
13. The prosthetic conduit system of claim 1, wherein the attachment portion comprises a flange. 15
14. The prosthetic conduit system of claim 11, wherein at least one of the first stent segment and the second stent segment comprises nitinol.
15. The prosthetic conduit system of claim 1, wherein the expandable 20 secondary conduit comprises a first stent segment at the first open end and a second stent segment at the second open end.
16. The prosthetic conduit system of claim 15, wherein the first stent segment and the second stent segment comprise a single stent extending from the first 25 open end to the second open end.
17. The prosthetic conduit system of claim 16, wherein at least one of the first stent segment and the second stent segment comprises nitinol. 30
18. A prosthetic conduit substantially as herein described with reference to the accompanying drawings.
19. A prosthetic conduit system as defined in any one of claims 1, 2 and 4 to 17, and being substantially as herein described with reference to the 35 accompanying drawings. 4111574_1 (GHMatters) P83106.AU.1 26/02/13
AU2013201110A 2007-08-08 2013-02-26 Endoluminal prosthetic conduit systems and method of coupling Active AU2013201110B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013201110A AU2013201110B2 (en) 2007-08-08 2013-02-26 Endoluminal prosthetic conduit systems and method of coupling

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/835,789 2007-08-08
AU2008284355A AU2008284355B2 (en) 2007-08-08 2008-08-01 Endoluminal prosthetic conduit systems and method of coupling
AU2013201110A AU2013201110B2 (en) 2007-08-08 2013-02-26 Endoluminal prosthetic conduit systems and method of coupling

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2008284355A Division AU2008284355B2 (en) 2007-08-08 2008-08-01 Endoluminal prosthetic conduit systems and method of coupling

Publications (2)

Publication Number Publication Date
AU2013201110A1 true AU2013201110A1 (en) 2013-03-14
AU2013201110B2 AU2013201110B2 (en) 2015-06-04

Family

ID=47878276

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013201110A Active AU2013201110B2 (en) 2007-08-08 2013-02-26 Endoluminal prosthetic conduit systems and method of coupling

Country Status (1)

Country Link
AU (1) AU2013201110B2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135037B1 (en) * 2000-05-01 2006-11-14 Endovascular Technologies, Inc. System and method for forming a junction between elements of a modular endovascular prosthesis
US6645242B1 (en) * 2000-12-11 2003-11-11 Stephen F. Quinn Bifurcated side-access intravascular stent graft

Also Published As

Publication number Publication date
AU2013201110B2 (en) 2015-06-04

Similar Documents

Publication Publication Date Title
US8979920B2 (en) Endoluminal prosthetic conduit systems and method of coupling
US7232459B2 (en) Thoracic aortic aneurysm stent graft
US9907683B2 (en) Controlled deployable medical device and method of making the same
EP1000590B1 (en) An improved stent which is easly recaptured and repositioned within the body
EP2349084B1 (en) Stent graft fixation coupling
EP0964658B1 (en) Kink resistant bifurcated prosthesis
US8518096B2 (en) Elephant trunk thoracic endograft and delivery system
EP1356785B1 (en) Bifurcated endoluminal prosthetic assembly
WO2012040240A1 (en) Stent graft delivery systems and associated methods
WO2000045742A9 (en) Covered stent with encapsulated ends
US7556643B2 (en) Graft inside stent
AU2013201110B2 (en) Endoluminal prosthetic conduit systems and method of coupling
AU779171B2 (en) Kink resistant bifurcated prosthesis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: W. L. GORE & ASSOCIATES, INC.

Free format text: FORMER OWNER WAS: GORE ENTERPRISE HOLDINGS, INC.